Value Investing Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Graham Osborn who wrote (55438)	6/9/2015 12:00:47 PM
From: Paul Senior	of 78740

TARO. Yes, it's not a great bargain at current price. I like the generic drug stocks if I can get them at about a 10 p/e. Taro somewhat higher than that now and on going forward (analysts' consensus earnings for next year). As a generality, maybe generic sales do decline over time. I don't know. TARO sales have increased most years though. financials.morningstar.com At current p/e, it's the cheapest (lowest p/e) of all the drug stocks that I am following. I stretch a little for adds if stock drops somewhat. Perhaps I am wrong to do this.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next